Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Clinical trial NCT06326476 · RECRUITING
Trial details
- NCT number
- NCT06326476
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2027-12-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.